Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Sanj K. Patel
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
autoimmune diseases
autoinflammatory diseases |
| gptkbp:foundedYear |
2015
|
| gptkbp:founder |
Sanj K. Patel
|
| gptkbp:headquartersLocation |
gptkb:Lexington,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kiniksa Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:product |
ARCALYST (rilonacept)
KPL-404 KPL-716 |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
KNSA
|
| gptkbp:website |
https://www.kiniksa.com/
|
| gptkbp:bfsParent |
gptkb:Baker_Bros._Advisors
|
| gptkbp:bfsLayer |
7
|